Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia

A randomized controlled trial

David Johnson, Carmel Hawley, Brenda Rosser, Elaine Beller, Charles Thompson, Robert Fassett, Paolo Ferrari, Stephen MacDonald, Eugenie Pedagogos, Alan Cass

Research output: Contribution to journalComment/debateResearch

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalBMC Nephrology
Volume9
Issue number1
Publication statusPublished - 2008
Externally publishedYes

Cite this

Johnson, D., Hawley, C., Rosser, B., Beller, E., Thompson, C., Fassett, R., ... Cass, A. (2008). Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial. BMC Nephrology, 9(1), 1-7.
Johnson, David ; Hawley, Carmel ; Rosser, Brenda ; Beller, Elaine ; Thompson, Charles ; Fassett, Robert ; Ferrari, Paolo ; MacDonald, Stephen ; Pedagogos, Eugenie ; Cass, Alan. / Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia : A randomized controlled trial. In: BMC Nephrology. 2008 ; Vol. 9, No. 1. pp. 1-7.
@article{efc2369b0bd445f89342af42d2336b01,
title = "Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial",
author = "David Johnson and Carmel Hawley and Brenda Rosser and Elaine Beller and Charles Thompson and Robert Fassett and Paolo Ferrari and Stephen MacDonald and Eugenie Pedagogos and Alan Cass",
year = "2008",
language = "English",
volume = "9",
pages = "1--7",
journal = "BMC Nephrology",
issn = "1471-2369",
publisher = "BioMed Central",
number = "1",

}

Johnson, D, Hawley, C, Rosser, B, Beller, E, Thompson, C, Fassett, R, Ferrari, P, MacDonald, S, Pedagogos, E & Cass, A 2008, 'Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial', BMC Nephrology, vol. 9, no. 1, pp. 1-7.

Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia : A randomized controlled trial. / Johnson, David; Hawley, Carmel; Rosser, Brenda; Beller, Elaine; Thompson, Charles; Fassett, Robert; Ferrari, Paolo; MacDonald, Stephen; Pedagogos, Eugenie; Cass, Alan.

In: BMC Nephrology, Vol. 9, No. 1, 2008, p. 1-7.

Research output: Contribution to journalComment/debateResearch

TY - JOUR

T1 - Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia

T2 - A randomized controlled trial

AU - Johnson, David

AU - Hawley, Carmel

AU - Rosser, Brenda

AU - Beller, Elaine

AU - Thompson, Charles

AU - Fassett, Robert

AU - Ferrari, Paolo

AU - MacDonald, Stephen

AU - Pedagogos, Eugenie

AU - Cass, Alan

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=50249092167&partnerID=8YFLogxK

M3 - Comment/debate

VL - 9

SP - 1

EP - 7

JO - BMC Nephrology

JF - BMC Nephrology

SN - 1471-2369

IS - 1

ER -

Johnson D, Hawley C, Rosser B, Beller E, Thompson C, Fassett R et al. Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial. BMC Nephrology. 2008;9(1):1-7.